Linda V Stevens-schilsky, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1440 W Walnut St, Jacksonville, IL 62650 Phone: 217-243-3543 |
Hasan Farid Hasan Othman, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 15 Founders Ln, Jacksonville, IL 62650 Phone: 217-243-0300 Fax: 217-245-6775 |
Dr. Rosemary Takyi Koeppel, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 15 Founders Ln, Suite 100, Jacksonville, IL 62650 Phone: 217-243-0300 Fax: 217-245-6775 |
Dr. Margaret Ann Wilson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 814 West State Street, Jacksonville, IL 62650 Phone: 217-245-1232 Fax: 217-243-6765 |
Dr. Adam Norton, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 15 Founders Ln, Jacksonville, IL 62650 Phone: 217-291-1041 |
Dr. Steven T Lillpop, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1600 W Walnut St, Jacksonville, IL 62650 Phone: 217-245-5437 Fax: 217-243-3113 |
News Archive
Mylan Laboratories Inc. has announced that the United States District Court for the Southern District of New York has ruled that Mylan's 10 mg and 20 mg omeprazole delayed-release capsules, which are the generic versions of AstraZeneca LP's Prilosec, do not infringe patents asserted against it by AstraZeneca.
While the onset of inflammatory bowel disease in adulthood is tied to a higher mortality, the actual number of deaths has been falling, a Swedish study from Karolinska Institutet published in the journal Gut reports.
The Republic of Belarus Ministry of Health has approved expanding the ongoing clinical trial of CureLab Oncology's Elenagen, an experimental DNA therapy, to include two new arms: 1) hormone-resistant breast cancer; and 2) hormone-resistant metastatic prostate cancer.
Some 16,000 registered nurses at 39 hospitals at three Catholic hospital chains in California and Nevada will join a one-day strike and picket October 30 as RNs step up the protest over poor readiness by many hospitals to confront the H1N1 pandemic, the California Nurses Association/National Nurses Organizing Committee (CNA/NNOC) announced today.
A major 12-year study based on a Taiwanese population cohort has demonstrated that not only does diabetes increase the risk of developing Parkinson's disease more than 2-fold, the use of sulfonylureas, commonly used as treatment for diabetes, increases the risk further by about 57%. This study also found that by including metformin in the therapy, no increased risk in developing Parkinson's disease was recorded.
› Verified 2 days ago